InvestorsHub Logo
Followers 153
Posts 17795
Boards Moderated 1
Alias Born 01/08/2007

Re: None

Thursday, 02/27/2020 11:27:29 AM

Thursday, February 27, 2020 11:27:29 AM

Post# of 279
OK, let me get this right, they received FDA approval for ESOcheck, which test for esophogial cancer, which is a rapidly growing concern due to the amount of GERD out there (1 in 10 have GERD), and that mean millions and millions of people could use this test, and the share price only moves a fraction of what it was prior to approval? THis should be a $10 plus stock... what am I missing here?


In cheepo we trust!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PAVM News